MedPath

Comparison of Efficacy and Safety between Warfarin, Rivaroxaban and Edoxaban in patients with acute pulmonary embolism in showa university

Not Applicable
Not yet recruiting
Conditions
Acute pulmonary embolism
Registration Number
JPRN-UMIN000020069
Lead Sponsor
Division of Cardiology, Department of Medicine,Showa university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

CrCL less than 30ml/min Patients with acute bleeding Patients with active malignancy Patients needed PCPS,IABP and aortic sheathes Contraindication of each drug

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath